Can One Safety Assessment Cover Several Markets

A brand owner asked me something like this recently: "I already paid a safety assessor for my EU file, can I just send that same document to my UK and Gulf distributors and call it done?" Partially, yes. Fully, no. And the gap between those two answers is where a lot of small exporters get stuck paying for the same work twice, or worse, skipping work they actually needed.

What a safety assessment really is

Under Regulation (EC) No 1223/2009, the EU requires a Cosmetic Product Safety Report, the CPSR, signed by a qualified safety assessor, sitting inside the broader Product Information File maintained by an EU-established Responsible Person. It's a substantive technical document: it looks at the formulation, the toxicological profile of each ingredient, exposure conditions, and concludes the product is safe for its intended use. That underlying scientific analysis doesn't change depending on which country the product is sold in, because the chemistry and the exposure scenario are the same product either way.

That's the part that travels well. The formulation-level toxicology, the exposure assessment logic, the core safety conclusion, all of that is reusable evidence.

What doesn't travel automatically

The problem is that "safety assessment" as a legal requirement is bundled differently market to market, and the bundling is what doesn't transfer.

• UK: needs its own Responsible Person and its own notification through the SCPN system with OPSS. The underlying safety science can lean on the same assessor and the same report, but the regulatory relationship, and often the formal paperwork trail, needs to exist independently for the UK market.
• Gulf markets: requirements vary by country and by which regional framework applies, and many still expect local registration steps or local agent involvement that an EU-only PIF doesn't satisfy on its own.
• ASEAN: the region works from a harmonized cosmetic directive, but each of the ten member states still runs its own national notification process. A safety file that supports an EU CPSR is useful supporting evidence, but it doesn't substitute for going through each country's own system if you're selling in more than one ASEAN market.

So what's the actual answer

Treat the safety assessment as two layers. The bottom layer is the scientific substance: ingredient safety data, concentration limits, exposure modeling, the assessor's professional conclusion. That layer is genuinely reusable and there's no reason to redo the toxicology from scratch for every market, assuming the formulation is identical and the assessor's conclusions are portable in substance.

The top layer is the regulatory wrapper: who is legally responsible in that market, what format the documentation needs to take, what portal or system it gets filed through, and what local-language or local-agent requirements exist. That layer is market specific almost everywhere, and no single filing satisfies it for multiple jurisdictions.

A sensible workflow looks like:

1. Commission one solid, well-documented safety assessment covering the actual formulation.
2. Reuse that underlying science as supporting evidence everywhere you sell.
3. Treat the notification, the Responsible Person appointment, and the market-specific filing as separate steps required in each jurisdiction, done once per market, not once total.

A caution on this being general guidance

Gulf and ASEAN specifics shift by country and by year, and this article isn't a substitute for checking the exact current requirements of wherever you're actually shipping. If you're expanding into a new market for the first time, it's worth a direct check with that market's regulator or a knowledgeable local counsel before assuming your EU paperwork gets you most of the way there. Sometimes it does. Sometimes the local rules are structured differently enough that you're starting closer to scratch than you'd like.

Cosmetic Comply is built around this exact layering problem, matching your formulation to INCI names and CAS numbers once and screening it against each market's specific restricted list, starting with Canada's Hotlist and expanding to more markets over time, so the ingredient-level work you've already done doesn't get thrown away every time you add a new country to your distribution.